Re: Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect.
Pierrefite-Carle
V
V
Gavelli
A
A
Brossette
N
N
Baqué
P
P
Benchimol
D
D
Bourgeon
A
A
Staccini
P
P
Rossi
B
B
D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use*; D019496:Cancer Vaccines / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000473:pathology; D043525:Cytosine Deaminase; D004195:Disease Models, Animal; D005437:Flucytosine / Q000008:administration & dosage / Q000627:therapeutic use*; D015552:Injections, Intralesional; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008297:Male; D009700:Nucleoside Deaminases / Q000235:genetics*; D011897:Random Allocation; D051381:Rats; D016019:Survival Analysis
D000964:Antimetabolites, Antineoplastic; D019496:Cancer Vaccines; D005437:Flucytosine; D009700:Nucleoside Deaminases; D043525:Cytosine Deaminase